Nanoviricides Inc., a Connecticut developer of drugs to fight challenging infectious diseases, has filed federal documents stating it is seeking to raise an indeterminate amount of funding in what appears to be a private investment in a public entity (PIPE).
Home Medical Equipment Providers Recognize Americans with Disabilities Act 20th Anniversary, Vow to Fight for Greater Access to CareJuly 26, 2010 10:37 am | by Bio-Medicine.Org | News | Comments
ARLINGTON, Va. , July 26 /PRNewswire-USNewswire/ -- Providers of home medical equipment and services, such as wheelchairs, oxygen therapy, and diabetic supplies, are recognizing the importance of the 20th anniversary of the Americans with Disabilities Act (ADA) today. Home medical...
Two Yale University scientists working on cell biology have been named as recipients of the 2010 Pioneer Award from the National Institutes of Health, with each recipient receiving a $2.5 million grant and laboratory support for five years.
Why do we enjoy things like bitter foods and horror films? And are we the only species that likes art? Paul Bloom, professor of psychology at Yale University and author of How Pleasure Works, explains our penchant for art and why we find some unpleasant things so enjoyable.
In 1911, two groups of explorers set out to be first to reach the South Pole. One claimed victory, and the other perished on the return trip. Ross MacPhee of the American Museum of Natural History and polar explorer John Huston discuss these scientific pioneers.
Based on mathematical models of the movement of fish, Maurizio Porfiri, engineering professor at Polytechnic Institute of NYU, built a robofish. When Porfiri let the robot go for a dip in the lab pool, the real fish started to mill about the robot and even follow it around.
Researchers meeting at the 18th international AIDS conference this week say a new vaginal gel can cut HIV transmission rates in half, if used properly. AIDS experts Anthony Fauci and Kevin Fenton join Ira Flatow to discuss the gel study, and other news from the conference.
How much oil is under the Gulf of Mexico and how did it get there? Columbia University geophysicist Roger Anderson, an expert in deepwater exploration and drilling, explains how the oil formed millions of years ago, and how companies go about finding and extracting it.
Influential and outspoken climatologist Stephen Schneider died this week of an apparent heart attack. Schneider's friend and colleague Dan Kammen describes Schneider's contributions to climate change research, and recalls the man he knew as "a wonderful, fearless soul."
Lawrence medical device maker NxStage Medical Inc. saw revenue for the second quarter of 2010 jump 21 percent, and managed to cut losses by nearly one third.
(Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)) As the Accreditation Council for Graduate Medical Education seeks to further limit residents' work hours, a new study reports that outcomes in two common surgeries were similar among residents who...
According to a nice article recently posted by David Lammers on System Level Design's blog, Through-silicon vias (TSVs) are in various stages of late development, but design and manufacturing challenges remain before companies can gain the full benefits of the third dimension.
Laser technology company GSI Group Inc. reported late Friday that it had completed its planned restructuring and emerged from its Chapter 11 bankruptcy protection. The Bedford-based company has has cut its debt load from $210 million to $107 million, officials report.
Abbott to Feature Novel Tests and New Upgrades to Testing Platforms at American Association for Clinical Chemistry Lab ExpoJuly 26, 2010 8:33 am | by Bio-Medicine.Org | News | Comments
ANAHEIM, Calif. , July 26 /- A first-of-its-kind test that detects HIV infection earlier than ever before in the United States ; a molecular assay for identification of two common sexually transmitted diseases; and an enhanced integrated analyzer offering significant workflow...
Abviva Announces Notice of Canadian Patent for Technology Used in Breast Cancer Diagnostics and TherapeuticsJuly 26, 2010 8:32 am | by Bio-Medicine.Org | News | Comments
SANTA BARBARA, Calif. , July 26 /- Abviva, Inc. (Pink Sheets: ABVV), a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent...